Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee OKs reimbursement change aimed at widening access to RSV monoclonal shot for infants
Summary
Lawmakers passed House Bill 1619, a measure to add an RSV monoclonal antibody to the Vaccines for Children reimbursement program, raising the administrative fee to encourage clinics to stock and administer the product, sponsors and medical groups said.
House Bill 1619 passed the Senate Public Health, Welfare and Labor Committee after extensive sponsor testimony describing access problems for a monoclonal-antibody product that reduces the risk that infants will be hospitalized with respiratory syncytial virus (RSV).
Representative Zach Gramlich, sponsor, recounted difficulty obtaining the product for his infant daughter, including…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
